Cortrophin Gel is indicated for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis and rheumatoid arthritis and excess urinary protein due to nephrotic syndrome.
The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products and a pipeline of seven additional products.
The Specialty Pharmacy Service Excellence Award is reserved for an industry professional who is not a pharmacist but has demonstrated a commitment to delivering high-quality service and care to patients.